Algorithm for neoadjuvant chemotherapy in nonmetastatic upper tract urothelial carcinoma, Asumi Nirazuka, Keita Izumi, Erika Ikezoe, Minoru Inoue, Hiroki Tsujioka, Kinotaro Hasegawa, Akiyoshi Oosaka, Yuka Yasuda, Akinori Nakayama, Kiyoshi Setoguchi, Kazutaka Saito., 25 Apr. 2024, Poster presentation
Testicular sperm retrieval in hemodialysis patients with sexual dysfunction, Akiyoshi Oosaka, Toshiyuki Iwahata, Erika Ikezoe, Minoru Inoue, Hiroki Tsujioka, Kintaro Hasegawa, Nirazuka Asumi, Miho Sugie, Yuka Yasuda, Keita izumi, Akinori Nakayama, Hiroshi Okada, Kazutaka Saito.
Prognostic impact of bone metastasis in up front androgen receptor-axis-targeted therapy for metastatic castration-sensitinve prostate vancer prostate cancer, Akinori Nakayama, Erika Ikezoe, Minoru Inoue, Hiroki Tsujioka, Asumi nirazuka, keita Izumi, Kiyoshi Setoguchi, Kazutaka Saito., 26 Apr. 2024, Poster presentation
Impact of C-reactive protein kinetics on the prognosis of the patient with metastatic urotherial carcinoma treated with enfortumab vedotin, Hiroki Tsujioka, Keita Izumi, Yusuke Hara, Erika Ikezoe, Kintaro Hasegawa, Asumi Nirazuka, Akiyoshi Oosaka, Toshiuki Iwahata, Akinori Nakayama, Kiyoshi Setoguchi, Kazutaka Saito, The 112th Annual Meeting of the Japanese Urological Associarion, 18 Apr. 2025, 17 Apr. 2025, 19 Apr. 2025, Poster presentation, Japan
Timing of radiographic progression on prostate-specific antigen kinetics in metastatic castration-sensitive prostate cancer patients received upfront therapy, Erika Ikezoe, Akinori Nakayama, Yusuke Hara, Hiroki Tsujioka, Asumi Nirazuka, Kintaro Hasegawa, Keita Izumi, Kiyoshi Setoguchi, Kazutaka Saito, The 112th Annual Meeting of the japanese Urological Association, 17 Apr. 2025, 17 Apr. 2025, 19 Apr. 2025, Oral presentation, Japan, False
Is the sperm DNA fragmentation index a good indicator for treatment selection in the era of modern assisted reproductive technology?, Hiroshi Okada, Toshiuki Iwahata, Takashi Tanaka, Hiroki Tsujioka, Kintaro Hasegawa, Miho Sugie, Akiyoshi Oosaka, Kazutaka Saito, Kouhei Sugimoto, The 112th Annual Meeting of the Japanese Urological Associarion, 17 Apr. 2025, 17 Apr. 2025, 19 Apr. 2025, Japan, False
Clinical Significance of Peritoneal Closure in Transperitoneal Robotic-Assisted Radical Prostatectomy, Keita Izumi, Yusuke Hara, Erika Ikezoe, Hiroki Tsujioka, Kintaro Hasegawa, Asumi Nirazuka, Akiyoshi Oosaka, Toshiyuki Iwahata, Akinori Nakayama, Kiyoshi Setoguchi, Kazutaka Saito, The 112th Annual Meeting of the Japanese Urological Associarion, 19 Apr. 2025, 17 Apr. 2025, 19 Apr. 2025, Oral presentation, Japan, False
Evaluation of prognostic Factor for sperm DNA fragmentation, Akiyoshi Oosaka, Toshiyuki Iwahata,Yusuke Hara, Erika Ikezoe, Hiroki Tsujioka, Asumi Nirazuka, Kintaro Hasegawa, Miho Sugie, Keita Izumi, Akinori Nakayama, Kiyoshi Setoguchi, Hiroshi Okada, Kazutaka Saito, The 112th Annual Meeting of the Japanese Urological Associarion, 18 Apr. 2025, 17 Apr. 2025, 19 Apr. 2025, Japan, False
Initial Experience with triplent therapy for metastatic castration senstive prostate cancer, Yusuke Hata, Akiyoshi Nakayama, Erika Ikezoe, Minoru inoue, Hiroki Tsujioka, Asumi Nirazuka, Kintaro Hasehgawa, Akiyoshi Oosaka, Keita Izumi, Toshiuki Iwahata, Kiyoshi Setoguchi, Kazutaka Saito, The 112th Annual Meeting of the Japanese Urological Associarion, 18 Apr. 2025, 17 Apr. 2025, 19 Apr. 2025, Poster presentation, Japan, False
Clinical outcomes of enfortumab vedotin in patients with metastatic urothelial carcinoma: a retrospective single-institution analysis, 24 Apr. 2026, 23 Apr. 2026, 26 Apr. 2026, Poster presentation, False
Prognostic significance of Gleason Grade Group 5 in metastatic castration-sensitive prostate cancer treated with doublet therapy, 23 Apr. 2026, 23 Apr. 2026, 26 Apr. 2026, Oral presentation, False
Comparison of early outcomes in living renal transplant recipients with respect to arterial anastomosis: the internal versus the external iliac artery, 24 Apr. 2026, 23 Apr. 2026, 26 Apr. 2026, Poster presentation, False
Initial experience with enfortumab vedotin and pembrolizumab therapy for advanced urothelial carcinoma, 24 Apr. 2026, 23 Apr. 2026, 26 Apr. 2026, Poster presentation, False
ABO Blood type may influence the efficacy of Bacllus Calmette-Guérin therapy in patients with non-muscle-invasive bladder cancer, 24 Apr. 2026, 23 Apr. 2026, 26 Apr. 2026, False
Efficacy of intravesical Bacillus Calmette-Guérin therapy in elderly patients age over eighty with non-muscle-invasive bladder cancer, 25 Apr. 2026, 23 Apr. 2026, 26 Apr. 2026, Poster presentation, False
Adjuvant Therapy with Pembrolizumab in Renal Cell Carcinoma: Real-World Experiences, 25 Apr. 2026, 23 Apr. 2026, 26 Apr. 2026, Poster presentation, False
Establishment of procedures to cryopreserve the prequbertal testicular tissue for induction of spermatogenesis in vitro: basic animal study, 25 Apr. 2026, 23 Apr. 2026, 26 Apr. 2026, Oral presentation, False